CDK4/6 as a therapeutic target in malignant melanoma

被引：0
|
作者：
Teh, Jessica L. [1 ]
Aplin, Andrew [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3096
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
    Sheppard, Karen E.
    McArthur, Grant A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5320 - 5328
  • [2] Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma
    Mahgoub, T.
    Eustace, A. J.
    Collins, D. M.
    Walsh, N.
    O'Donovan, N.
    Crown, J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 900 - 908
  • [3] Cdk4 as therapeutic target in bladder cancer
    Rubio, Carolina
    Martinez-Fernandez, Monica
    Segovia, Cristina
    Lodewijk, Iris
    Segrelles, Carmen
    Lopez-Calderon, Fernando F.
    Santos, Mirentxu
    Garcia-Escudero, Ramon
    Gomez-Rodriguez, Ma Jose
    de Velasco, Guillermo
    Munera, Ester
    Villacampa, Felipe
    de la Rosa, Federico
    Castellano, Daniel
    Duenas, Marta
    Paramio, Jesus M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 617 - 617
  • [4] CDK4 and 6 as therapeutic targets in human melanoma - just redundant proteins?
    Briand, C.
    Jerney, W.
    Blunder, S.
    Schicher, N.
    Pehamberger, H.
    Hoeller, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 794 - 794
  • [5] PALOMA-3 confirms that CDK4/6 is a key therapeutic target
    Alessia Errico
    Nature Reviews Clinical Oncology, 2015, 12 : 436 - 436
  • [6] PALOMA-3 confirms that CDK4/6 is a key therapeutic target
    Errico, Alessia
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (08) : 436 - 436
  • [7] CDK4 expression in chordoma: A potential therapeutic target
    Liu, Tang
    Shen, Jacson K.
    Choy, Edwin
    Zhang, Yu
    Mankin, Henry J.
    Hornicek, Francis J.
    Duan, Zhenfeng
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2018, 36 (06) : 1581 - 1589
  • [8] Amplification of CDK4 and MDM2 in malignant melanoma
    Muthusamy, V
    Hobbs, C
    Nogueira, C
    Cordon-Cardo, C
    McKee, PH
    Chin, L
    Bosenberg, MW
    GENES CHROMOSOMES & CANCER, 2006, 45 (05): : 447 - 454
  • [9] Novel therapeutic strategy for melanoma based on albendazole and the CDK4/6 inhibitor palbociclib
    Lin Zhu
    Qin Yang
    Rong Hu
    Yanan Li
    Yuanliang Peng
    Hong Liu
    Mao Ye
    Bin Zhang
    Peihe Zhang
    Feng Liu-Smith
    Hui Li
    Jing Liu
    Scientific Reports, 12
  • [10] Novel therapeutic strategy for melanoma based on albendazole and the CDK4/6 inhibitor palbociclib
    Zhu, Lin
    Yang, Qin
    Hu, Rong
    Li, Yanan
    Peng, Yuanliang
    Liu, Hong
    Ye, Mao
    Zhang, Bin
    Zhang, Peihe
    Liu-Smith, Feng
    Li, Hui
    Liu, Jing
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345